ORMP reports purportedly positive data for oral insulin, but the share price is down slightly: http://finance.yahoo.com/news/oramed-pharmaceuticals-reports-positive-top-122900437.html (ORMP’s PR) http://in.reuters.com/article/2014/10/22/us-oramed-study-idINKCN0IB1HQ20141022 (Reuters)